Source: Financial Modeling Prep · peers by sector/industry
Insider activity (SEC Form 4)
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Valuation
Trading at 29.6× earnings vs its 33.5× historical median P/E.
Fair value ≈ $114.13 · price $100.99 today
Undervalued · 12% below
Loading valuation…
Fair-value line = the stock's median historical P/E × earnings. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
UnitedHealth Group shares rose after the company reaffirmed its 2025 earnings guidance during investor meetings scheduled for Sept. 8–10. The SEC filing notes that executives plan to maintain the previously shared adjusted EPS expectations from July 29, 2022.
The guidance accounts for the August 2025 Amedisys acquisition, which is expected to be “moderately dilutive” to adjusted EPS due to financing and integration costs. Investor meetings may also cover strategy, market positions, and previously disclosed results. The market reacted positively, reflecting confidence in UnitedHealth’s ability to maintain earnings forecasts despite short-term financial impact from the acquisition.
$UNH $AMED
$TWLO $AMED $UNH
Twilio will replace Amedisys in the S&P MidCap 400 effective prior to the opening of trading on Tuesday, August 19.
-- UnitedHealth Group acquired Amedisys in a deal completed August 14.
$AMED NASDAQ Equity Corporate Actions Alert # 2025 - 439
Information Regarding the Merger of Amedisys Inc (AMED)
https://www.nasdaqtrader.com/TraderNews.aspx?id=ECA2025-439
At a special meeting held on September 8, 2023 the shareholders of Amedisys Inc (AMED) approved a merger with UnitedHealth Group Incorporated (UNH). The merger closed today, August 14, 2025.
Merger consideration: AMED shareholders received $101.00 for each share held.
$UNH
$AMED a healthcare company with $2.4 billion in annual revenue and a market capitalization of $3.32 billion, announced Thu the completion of its merger with UnitedHealth Group Incorporated, making Amedisys a wholly owned subsidiary of UnitedHealth Group.
https://za.investing.com/news/sec-filings/amedisys-completes-merger-with-unitedhealth-group-delists-from-nasdaq-93CH-3840006
